Antiretroviral Therapy Initiation and Changes in Self-Reported Depression.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 28419238.
- Also identified by DOI 10.1093/cid/cix217 and PMC identifier 6889045.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In this retrospective study of treatment-naive PLWH initiating antiretroviral therapy, the score for the depression scale of the Patient Health Questionnaire (PHQ-9) was significantly higher at baseline (median, 6.0; interquartile range, 2-11) than at 12 months (3.0; 0-8; P < .001). Baseline depression and lack of insurance are associated with 12-month depression, but receipt of efavirenz-based antiretroviral therapy is not.
Medical subject headings
- Anti-HIV Agents
- Antiretroviral Therapy, Highly Active
- Depression
- HIV Infections